Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 178, Issue 3, Pages 1145-1152Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2010.11.059
Keywords
-
Categories
Funding
- German Cancer Aid
- German Research Foundation
- BayGene
- Medical Faculty of the University of Regensburg (ReForM)
Ask authors/readers for more resources
Recently, we have shown that down-regulation of methylthioadenosine phosphorylase (MTAP) in hepatocellular carcinoma (HCC) cells enhances the invasive potential and the resistance against cytokines. Here, we aimed at investigating the molecular mechanism underlying this tumor-promoting effect and expanded the analysis to a large series of human HCC tissues. Liquid chromatography tandem mass spectrometry revealed that reduced MTAP expression resulted in higher intra- and extracellular concentrations of 5'-deoxy-5'-methylthioadenosine (MTA) in cultivated HCC cells and, concordantly, higher levels of MTA in HCC tissue. MTA induced matrix metalloproteinase (MMP) and interleukin-8 transcription in HCC cells in vitro, accompanied by enhanced proliferation and activation of the transcription factor NF kappa B. In addition, MTA secreted by HCC cells induced expression of fibroblast growth factor-2 and MMP1 in stromal myofibroblasts. In human HCC tissues, MTAP mRNA correlated inversely with MTA levels, and immuncohistochemical analysis of a tissue microarray of 140 human HCCs revealed that low mTAP protein expression correlated with advanced tumor stages. In conclusion, MTAP deficiency results in accumulation of MTA, which is associated with increased tumorigenicity. These data further indicate MTAP as a tumor suppressor in HCC, and MTA as a potential biomarker for HCC progression. (Am J Pathol 2011, 178:1145-1152; DOI: 10.1016/j.ajpath.2010.11.059)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available